biotech · Propionic Acidemia · Isolated Methylmalonic Acidemia Due to Methylmalonyl-CoA Mutase Deficiency
SOM Biotech
Moderna Biotech Spain
SOM Biotech clinical programs — 6 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Barcelona, ES
- Founded
- 2009
- Employees
- 14
- Programs
- 10
- Drugs
- 27
- Patents
- 0
SOM Biotech projects
6 ClinicalTrials.gov programs sponsored by SOM Biotech.
SOM Biotech has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
0.9% Sodium Chloride Injection, mRNA-3705
Moderna Biotech Spain
Isolated Methylmalonic Acidemia Due to Methylmalonyl-CoA Mutase Deficiency
1 trial -
SODIUM CHLORIDE SOLUTION 0.9%, mRNA-1345
Moderna Biotech Spain
Respiratory syncytial virus
1 trial -
mRNA 3210-P101
Moderna Biotech Spain
Participants with Phenylketonuria
1 trial -
mRNA-3745-P102
Moderna Biotech Spain
Glycogen storage disease type 1a (GSD1a)
1 trial -
mRNA-3927
Moderna Biotech Spain
Propionic Acidemia
1 trial -
mRNA-3927-P101
Moderna Biotech Spain
Propionic Acidemia
1 trial
Frequently asked questions
How many clinical projects does SOM Biotech have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.